




|
Multiple Sclerosis - Homocysteine Homocysteine is elevated in the blood and CSF of MS patients. A functional B12 deficiency may be present and possible injectable I.M. vitamin B12 therapy may be warranted. [Biogenic Amines, 1995;11(6):479-485. 24073 (1997)] Summary Interview |
|
Multiple Sclerosis - Picotesla electromagnetic therapy Picotesla electromagnetic therapy - The amplitude or intensity of the magnetic field is extremely low. The electromagnetic field device produces an alternating current field of an amplitude of 7.5 picotesla (i.e., 7.5 x 10-12 Tesla or 0.000075 mG) which can be measured with a superconducting magnetometer. The amplitude of the signal field used in the treatment is several million fold weaker than the background signal of the earth's magnetic field. [Int J Neurosci, 1995;83:187-198. 24113 / Int J Neurosci, 1995;83:69-79. 23966 / Int J Neurosci, 1995;82:223-242. 22870 / Int J Neurosci,1996;84:157-164. 24371 (1997)] |
|
Multiple Sclerosis - Vitamin D Vitamin D supplementers 40% lower risk. [Ann Pharmacother, 2006 May 9 [Epub ahead of print]. 44285 (6/2006)] Summary Interview |
|
Multiple Sclerosis - Vitamin D - 2 Vitamin D 5000 IU/d from 20 gm of cod liver oil. [Ann Pharmacother, 2006 May 9 [Epub ahead of print]. 44285 (6/2006)] Summary Interview |
|
Multiple Sclerosis - Vitamin D - 3 Vitamin D lower levels associated with multiple sclerosis. [J Am Diet Assoc, Mar 2006;106(3):418-24. 44101/44585 (5/2006)] Summary Interview |
|
Multiple Sclerosis - vitamin d - 47965 Vitamin D at 2000 IU can reduce pediatric relapse by one half. Increasing vitamin D by 10 ng/mL correlated with a 34 percent decrease in the rate of subsequent relapses. [Ann Neurol, 2010;67(5):618-24. 47965 (09/2010)] Summary Interview PubMed |
| Powered by Sigsiu.NET | ![]() |